Tyvaso 0.6 MG refill kit
Ended Awarded
- Contract number
- 36C24526N0302
- Awardee
-
United Therapeutics Corp UEI KK5FBFA43JS7
- Awarding agency
-
Veterans Integrated Service Network 5
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $17,614
Award facts
- Contract value 100% obligated
- $17,613.64 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Bartlett, TN 38134, USA
Award details come from SAM.gov/FPDS.
About this award
The U.S. Department of Veterans Affairs, Veterans Integrated Service Network 5 (VISN 5), awarded a delivery order to United Therapeutics Corp on February 4, 2026, for Tyvaso 0.6 mg refill kits valued at $17,613.64 with completion scheduled for February 6, 2026. This firm fixed-price delivery order operates under the GSA Federal Supply Schedule for Pharmaceuticals and Drugs (FSS-61-IB) and includes no set-aside designation. The award is issued under United Therapeutics' existing single-award Blanket Purchase Agreement with the VA National Acquisition Center, valued at $207.1 million through April 23, 2026, which encompasses critical pharmaceutical products including Tyvaso, Remodulin, Orenitram, and Unituxin for treating pulmonary arterial hypertension and select oncology conditions affecting the veteran population.
United Therapeutics Corp, a biotechnology manufacturer headquartered in Silver Spring, Maryland, is a self-certified small disadvantaged business and primary federal supplier of specialized pharmaceutical products to the Department of Veterans Affairs. The Tyvaso refill kits delivered under this order support the VA's mission to provide essential medications to veterans across multiple regions. The BPA structure enables the Veterans Health Administration to efficiently manage supply chains for these critical therapeutic products while maintaining cost predictability and flexibility in order quantities and timing across the VA's integrated healthcare network nationwide.
Quick answers
Who was awarded contract 36C24526N0302?
36C24526N0302 was awarded to United Therapeutics Corp by Veterans Integrated Service Network 5 (Veterans Health Administration) on February 4, 2026.
How much is contract 36C24526N0302 worth?
The government has obligated $17,614 on 36C24526N0302.
Is contract 36C24526N0302 an order under another contract?
Yes. 36C24526N0302 is a delivery order under 36F79720D0104, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C24526N0302 competed?
The extent of competition for 36C24526N0302 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award